glp-1 receptor agonist nephrolithiasis agonists and next-generation metabolic hormone therapies in chronic kidney disease Nephroprotective effects of GLP-1 receptor
Description
2022 Jan 10;13(1):92
Liver function effects of SGLT2 inhibitor and GLP-1 receptor agonist combination treatment in patients with type 2 diabetes (post hoc analysis of RECAP study)
There are also serious side effects that can happen, but are rare, which can include: pancreatitis, medullary thyroid cancer, acute kidney injury and worsening diabetes-related retinopathy
Emergance of combination therapy
Funding Not applicable
Under no circumstances should it ever be considered medical or actionable advice
